• Estimating health adjusted age at death (HAAD) 

      Johansson, Kjell Arne; Økland, Jan-Magnus; Skaftun, Eirin Krüger; Bukhman, Gene; Norheim, Ole Frithjof; Coates, Matthew M.; Haaland, Øystein Ariansen (Journal article; Peer reviewed, 2020-07-14)
      Objectives: At any point in time, a person’s lifetime health is the number of healthy life years they are expected to experience during their lifetime. In this article we propose an equity-relevant health metric, Health ...
    • Estimating impact of food choices on life expectancy: A modeling study 

      Fadnes, Lars T.; Økland, Jan-Magnus; Haaland, Øystein Ariansen; Johansson, Kjell Arne (Journal article; Peer reviewed, 2022)
      Background Interpreting and utilizing the findings of nutritional research can be challenging to clinicians, policy makers, and even researchers. To make better decisions about diet, innovative methods that integrate best ...
    • Life expectancy can increase by up to 10 years following sustained shifts towards healthier diets in the United Kingdom 

      Fadnes, Lars T.; Celis-Morales, Carlos; Økland, Jan-Magnus; Parra-Soto, Solange; Livingstone, Katherine M.; Ho, Frederick K.; Pell, Jill P.; Balakrishna, Rajiv; Javadi Arjmand, Elaheh; Johansson, Kjell Arne; Haaland, Øystein Ariansen; Mathers, John C. (Journal article; Peer reviewed, 2023)
      Adherence to healthy dietary patterns can prevent the development of non-communicable diseases and affect life expectancy. Here, using a prospective population-based cohort data from the UK Biobank, we show that sustained ...
    • On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: A prospective cohort study from 2013 to 2017 

      Aas, Christer Frode; Vold, Jørn Henrik; Skurtveit, Svetlana; Odsbu, Ingvild; Chalabianloo, Fatemeh; Økland, Jan-Magnus; Leiva, Rafael Alexander Mo; Vickerman, Peter; Johansson, Kjell Arne; Fadnes, Lars T. (Journal article; Peer reviewed, 2020)
      Objectives We aimed to calculate cumulative hepatitis C virus (HCV) treatment coverage among individuals enrolled in opioid agonist therapy (OAT) in Norway between 2013 and 2017 and to document the treatment transition to ...